LifeVantage (LFVN) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
18 Sep, 2026Executive summary
Annual meeting scheduled for November 5, 2026, with voting available online or in person.
Shareholders are encouraged to review proxy materials and annual report before voting.
Voting matters and shareholder proposals
Election of six directors for terms expiring at the next annual meeting or until successors are qualified.
Advisory vote to approve executive compensation for named executive officers.
Ratification of Deloitte & Touche, LLP as independent auditor for fiscal year ending June 30, 2027.
Provision to conduct any other business properly brought before the meeting.
Board of directors and corporate governance
Six nominees for director positions: Rajendran Anbalagan, Michael A. Beindorff, Raymond B. Greer, Dayton Judd, Darwin K. Lewis, and Terrence Moorehead.
Latest events from LifeVantage
- Board elections, say-on-pay, and auditor ratification headline a governance-focused proxy.LFVN
Proxy filing - Revenue and earnings fell, but gross margins and liquidity remain strong.LFVN
Q4 2026 - LoveBiome integration, scientific advances, and global expansion set the stage for 2026 growth.LFVN
Water Tower Research Fireside Chat Series - Leadership change and international expansion drive growth, supported by strong financials.LFVN
WTR Insights Conference: Powered by The Small Cap Showcase - Recurring revenue, product innovation, and global expansion drive strong financial performance.LFVN
Investor presentation - Revenue and earnings fell sharply in Q3 FY2026, offset by cost controls and new initiatives.LFVN
Q3 2026 - Direct sales, science-driven products, and global expansion drive strong growth prospects.LFVN
Water Tower Research Insights Conference - Strong FY25 results and innovative wellness products fuel growth and global expansion.LFVN
Investor presentation - Adjusted EBITDA rose 44.7% despite a 6.2% revenue decline, with new launches expected.LFVN
Q4 2024